Glucocorticoid receptor function in vitro in patients with major depression

Area of Science:

• Neuroendocrinology
• Psychiatry
• Molecular Biology

Background:

• Major depression is associated with impaired glucocorticoid receptor (GR)-mediated negative feedback on the hypothalamic-pituitary-adrenal (HPA) axis, termed GR resistance.
• Reduced GR function in peripheral tissues of depressed patients has been observed, indicated by decreased sensitivity to glucocorticoids.
• Similar GR regulation in brain and peripheral tissues suggests peripheral studies can inform central mechanisms.

Purpose of the Study:

• To review in vitro studies investigating GR function in patients with major depression.
• To explore potential molecular mechanisms underlying GR resistance in depression.
• To highlight the relevance of peripheral in vitro studies for understanding central GR abnormalities and antidepressant treatment effects.

Main Methods:

• Review of existing in vitro studies examining glucocorticoid receptor (GR) function in peripheral tissues of patients with major depression.
• Analysis of molecular mechanisms potentially involved in GR resistance.
• Synthesis of findings from peripheral studies in the context of central HPA axis regulation.

Main Results:

• In vitro studies consistently show reduced GR function and sensitivity to glucocorticoids in peripheral tissues of depressed individuals.
• These peripheral alterations mirror some aspects of central HPA axis dysregulation observed in major depression.
• Antidepressant treatments have shown potential to resolve GR resistance.

Conclusions:

• In vitro studies of peripheral tissues are highly relevant for elucidating molecular mechanisms of GR abnormalities in major depression.
• Understanding peripheral GR function provides insights into central GR resistance and its modulation by antidepressant therapies.
• Peripheral GR studies offer a valuable model given the limited accessibility of brain GR in clinical depression research.